» Articles » PMID: 26554585

A Naturally Occurring Rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1

Overview
Journal PLoS One
Date 2015 Nov 12
PMID 26554585
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pandemic strains of HIV-1 (group M) encode a total of nine structural (gag, pol, env), regulatory (rev, tat) and accessory (vif, vpr, vpu, nef) genes. However, some subtype A and C viruses exhibit an unusual gene arrangement in which the first exon of rev (rev1) and the vpu gene are placed in the same open reading frame. Although this rev1-vpu gene fusion is present in a considerable fraction of HIV-1 strains, its functional significance is unknown.

Results: Examining infectious molecular clones (IMCs) of HIV-1 that encode the rev1-vpu polymorphism, we show that a fusion protein is expressed in infected cells. Due to the splicing pattern of viral mRNA, however, these same IMCs also express a regular Vpu protein, which is produced at much higher levels. To investigate the function of the fusion gene, we characterized isogenic IMC pairs differing only in their ability to express a Rev1-Vpu protein. Analysis in transfected HEK293T and infected CD4+ T cells showed that all of these viruses were equally active in known Vpu functions, such as down-modulation of CD4 or counteraction of tetherin. Furthermore, the polymorphism did not affect Vpu-mediated inhibition of NF-кB activation or Rev-dependent nuclear export of incompletely spliced viral mRNAs. There was also no evidence for enhanced replication of Rev1-Vpu expressing viruses in primary PBMCs or ex vivo infected human lymphoid tissues. Finally, the frequency of HIV-1 quasispecies members that encoded a rev1-vpu fusion gene did not change in HIV-1 infected individuals over time.

Conclusions: Expression of a rev1-vpu fusion gene does not affect regular Rev and Vpu functions or alter HIV-1 replication in primary target cells. Since there is no evidence for increased replication fitness of rev1-vpu encoding viruses, this polymorphism likely emerged in the context of other mutations within and/or outside the rev1-vpu intergenic region, and may have a neutral phenotype.

Citing Articles

HIV-1 Vpu restricts Fc-mediated effector functions in vivo.

Prevost J, Anand S, Rajashekar J, Zhu L, Richard J, Goyette G Cell Rep. 2022; 41(6):111624.

PMID: 36351384 PMC: 9703018. DOI: 10.1016/j.celrep.2022.111624.


SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue.

Kmiec D, Akbil B, Ananth S, Hotter D, Sparrer K, Sturzel C PLoS Pathog. 2018; 14(8):e1007269.

PMID: 30125328 PMC: 6117100. DOI: 10.1371/journal.ppat.1007269.


Unusual Fusion Proteins of HIV-1.

Langer S, Sauter D Front Microbiol. 2017; 7:2152.

PMID: 28119676 PMC: 5220186. DOI: 10.3389/fmicb.2016.02152.


Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.

Mack K, Starz K, Sauter D, Langer S, Bibollet-Ruche F, Learn G J Virol. 2017; 91(6).

PMID: 28077643 PMC: 5331793. DOI: 10.1128/JVI.02177-16.


Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins.

Hotter D, Sauter D, Kirchhoff F Small GTPases. 2016; 8(1):31-37.

PMID: 27275775 PMC: 5331900. DOI: 10.1080/21541248.2016.1189990.

References
1.
Shugars D, Smith M, Glueck D, Nantermet P, Seillier-Moiseiwitsch F, Swanstrom R . Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol. 1993; 67(8):4639-50. PMC: 237849. DOI: 10.1128/JVI.67.8.4639-4650.1993. View

2.
Purcell D, Martin M . Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol. 1993; 67(11):6365-78. PMC: 238071. DOI: 10.1128/JVI.67.11.6365-6378.1993. View

3.
Glushakova S, Baibakov B, Margolis L, Zimmerberg J . Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat Med. 1995; 1(12):1320-2. DOI: 10.1038/nm1295-1320. View

4.
Fouchier R, Meyer B, Simon J, Fischer U, Malim M . HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 1997; 16(15):4531-9. PMC: 1170079. DOI: 10.1093/emboj/16.15.4531. View

5.
PLATT E, Wehrly K, Kuhmann S, Chesebro B, Kabat D . Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol. 1998; 72(4):2855-64. PMC: 109730. DOI: 10.1128/JVI.72.4.2855-2864.1998. View